TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year (Emma Court/Bloomberg)

Emma Court / Bloomberg: TrialSpark, which wants to leverage its clinical trials management software into drug discovery, closed $156M Series C at a $1B+ valuation earlier this year  —  – TrialSpark expands from clinical trials into developing drugs  — Company raised $156 million, is valued at more than $1 billion

5 Training Tips from the Pros

Professional cyclists are among the toughest athletes in the world. But you don’t have to train like a pro to learn from them. In fact, training like a professional might not be the best fit for you. These five training tips from pros can be used by anyone that wants […]